Olgram
Bréhan-loudéac
About Olgram
Olgram is a biotechnology company that develops marine molecules for the prevention and control of chronic bacterial infections.Olgram has an original positioning to address this critical need by developing new products that will target, for the first time, dormant bacteria (responsible for infectious relapses) with a new class of anti-infectious.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.8M
- Funding stage: Seed
- Last round: Seed (Mar 2021)
- Website: olgram.com
- Phone: +33 (0)6 75 69 31 30
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/olgram-106038 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.